FMP
Pharvaris N.V.
PHVS
NASDAQ
Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients and is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States. The company was incorporated in 2015 and is based in Leiden, the Netherlands.
22.65 USD
1.4 (6.18%)
About
ceo
Mr. Berndt Axel Edvard Modig CPA, M.B.A.
sector
Healthcare
industry
Biotechnology
website
https://pharvaris.com
exchange
NASDAQ
Description
Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients and is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States. The company was incorporated in 2015 and is based in Leiden, the Neth...
CIK
0001830487
ISIN
NL00150005Y4
CUSIP
N69605108
Address
J.H. Oortweg 21
Phone
31 71 203 6410
Country
NL
Employee
82
IPO Date
Feb 5, 2021
Summary
CIK
0001830487
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
N69605108
ISIN
NL00150005Y4
Country
NL
Price
22.65
Beta
-3.12
Volume Avg.
91.55k
Market Cap
1.22B
Shares
-
52-Week
7.93-33.0
DCF
10.92
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-8.09
P/B
-
Website
https://pharvaris.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest PHVS News
It looks like there's no news available.
